Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
268.46
-2.56 (-0.94%)
At close: Mar 28, 2025, 4:00 PM
266.00
-2.46 (-0.92%)
After-hours: Mar 28, 2025, 7:58 PM EDT

Alnylam Pharmaceuticals Revenue

In the year 2024, Alnylam Pharmaceuticals had annual revenue of $2.25B with 22.97% growth. Alnylam Pharmaceuticals had revenue of $593.17M in the quarter ending December 31, 2024, with 34.90% growth.

Revenue (ttm)
$2.25B
Revenue Growth
+22.97%
P/S Ratio
15.24
Revenue / Employee
$1,070,592
Employees
2,100
Market Cap
34.75B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.25B419.95M22.97%
Dec 31, 20231.83B790.87M76.23%
Dec 31, 20221.04B193.13M22.88%
Dec 31, 2021844.29M351.43M71.31%
Dec 31, 2020492.85M273.10M124.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ALNY News

More News